470 nm LED Irradiation Inhibits the Invasiveness of CD133-positive Human Colorectal Cancer Stem Cells by Suppressing the Cyclooxygenase-2/prostaglandin E2 Pathway
Authors:
- 3 March 2021
- journal article
- research article
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 41 (3) , 1407-1420
Abstract
Background/Aim: Recurrence and metastasis of cancer caused by cancer stem cells (CSCs) is a challenge to overcome. Low level laser therapy is a new treatment strategy to suppress their invasiveness. We have assessed the inhibitory effects of 470 nm blue LED on the invasiveness of them to determine the molecular mechanisms of anti-invasiveness. Materials and Methods: The effects of blue LEDs on their viability, proliferation and invasion were analyzed using MTT and transwell methods. In addition, the anti-invasiveness effect of blue LED on them was evaluated by zymography, semi-quantitative RT-PCR and western blot analysis. Results: Irradiation with blue LED at 3 J/cm2 resulted in inhibition of their viability, proliferation and invasiveness. Their matrix metalloproteinase 2 (MMP-2) and MMP-9 activities were reduced by blue LED irradiation. Semi-quantitative RT-PCR also showed similar results. In addition, western blotting analyses showed that cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2) synthesis were significantly inhibited by LED irradiation in CD133+ colorectal CSCs. Conclusion: Down-regulation of the COX-2/PGE2 signaling pathway by blue LED irradiation led to reduce expression of MMP-2 and MMP-9, inhibiting the invasiveness of CD133+ colorectal CSC.Keywords
This publication has 34 references indexed in Scilit:
- CD133: a stem cell biomarker and beyondExperimental Hematology & Oncology, 2013
- CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-AnalysisPLOS ONE, 2013
- Immunohistochemical detection of CD133 is associated with tumor regression grade after chemoradiotherapy in rectal cancerMedical Oncology, 2012
- Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinomaJournal of Clinical Pathology, 2011
- Frequency and pattern of expression of the stem cell marker CD133 have strong prognostic effect on the surgical outcome of colorectal cancer patientsOncology Reports, 2010
- Survival Following Recurrence in Stage II and III Colon Cancer: Findings From the ACCENT Data SetJournal of Clinical Oncology, 2008
- Identification and expansion of human colon-cancer-initiating cellsNature, 2006
- A human colon cancer cell capable of initiating tumour growth in immunodeficient miceNature, 2006
- Visible laser and UV‐A radiation impact on a PNP degrading Moraxella strain and its rpoS mutantBiotechnology and Bioengineering, 2006
- Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma PreventionNew England Journal of Medicine, 2005